Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 2—February 2009
Research

Oseltamivir-Resistant Influenza Viruses A (H1N1), Norway, 2007–08

Siri H. Hauge, Susanne Dudman, Katrine Borgen, Angie Lackenby, and Olav HungnesComments to Author 
Author affiliations: Norwegian Institute of Public Health, Oslo, Norway (S.H. Hauge, S. Dudman, K. Borgen, O. Hungnes); Health Protection Agency, London, UK (A. Lackenby)

Main Article

Figure 1

Phylogenetic reconstruction of the H1 genes of influenza viruses A (H1N1) in Norway, 2007–08 season. The analysis was performed on an alignment spanning positions 84–1054 of viral RNA segment 4. Pairwise distances were calculated by using the Kimura 2-parameter model with a transition:transversion ratio of 2.0; the phylogenetic tree was constructed by the neighbor-joining method, as implemented in the programs DNADIST and NEIGHBOR in the PHYLIP package (14 15,). Published sequences were obtained

Figure 1. Phylogenetic reconstruction of the H1 genes of influenza viruses A (H1N1) in Norway, 2007–08 season. The analysis was performed on an alignment spanning positions 84–1054 of viral RNA segment 4. Pairwise distances were calculated by using the Kimura 2-parameter model with a transition:transversion ratio of 2.0; the phylogenetic tree was constructed by the neighbor-joining method, as implemented in the programs DNADIST and NEIGHBOR in the PHYLIP package (14 15,). Published sequences were obtained from the Influenza Sequence Database, Los Alamos National Laboratory (16). Boldface indicates viruses from the 2007–08 influenza season in Norway; red indicates oseltamivir-resistant viruses; blue, susceptible viruses. New sequences presented in this analysis have been deposited in GenBank (accession nos. CY036664–CY036694).

Main Article

References
  1. McKimm-Breschkin  J, Trivedi  T, Hampson  A, Hay  A, Klimov  A, Tashiro  M, Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother. 2003;47:2264–72. DOIPubMedGoogle Scholar
  2. Aavitsland  P, Hauge  S, Borgen  K. Rare usage of oseltamivir in Norway prior to emergence of oseltamivir resistant influenza A(H1N1) virus in the 2007–2008 season. 2008 International Conference on Emerging Infectious Disases; 2008 Mar 16–19; Atlanta. Addendum 11.
  3. Escuret  V, Frobert  E, Bouscambert-Duchamp  M, Sabatier  M, Grog  I, Valette  M, Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors. J Clin Virol. 2008;41:25–8. DOIPubMedGoogle Scholar
  4. Monto  AS, McKimm-Breschkin  JL, Macken  C, Hampson  AW, Hay  A, Klimov  A, Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother. 2006;50:2395–402. DOIPubMedGoogle Scholar
  5. Zambon  M, Hayden  FG. Position statement: global neuraminidase inhibitor susceptibility network. Antiviral Res. 2001;49:147–56. DOIPubMedGoogle Scholar
  6. World Health Organization. International Health Regulations (IHR) 2005, 2nd ed. [cited 2008 December 8]. Available from http://www.who.int/csr/ihr/IHR_2005_en.pdf
  7. Lackenby  A, Hungnes  O, Dudman  SG, Meijer  A, Paget  WJ, Hay  A, Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Euro Surveill. 2008;13. pii: 8026.
  8. Mishin  VP, Hayden  FG, Gubareva  LV. Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors. Antimicrob Agents Chemother. 2005;49:4515–20. DOIPubMedGoogle Scholar
  9. Ives  JA, Carr  JA, Mendel  DB, Tai  CY, Lambkin  R, Kelly  L, The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leaves virus severely compromised both in vitro and in vivo. Antiviral Res. 2002;55:307–17. DOIPubMedGoogle Scholar
  10. Lackenby  A, Democratis  J, Siqueira  M, Zambon  M. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies. Antivir Ther. 2008;809–20.PubMedGoogle Scholar
  11. Wetherall  NT, Trivedi  T, Zeller  J, Hodges-Savola  C, McKimm-Breschkin  JL, Zambon  M, Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol. 2003;41:742–50. DOIPubMedGoogle Scholar
  12. Fouchier  RA, Bestebroer  TM, Herfst  S, Van Der Kemp  L, Rimmelzwaan  GF, Osterhaus  AD. Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene. J Clin Microbiol. 2000;38:4096–101.PubMedGoogle Scholar
  13. Norwegian Institute of Public Health. The 2007/2008 influenza season in Norway [cited 2008 May 28]. Available from http://www.fhi.no/eway/default.aspx?pid=238&trg=MainLeft_5895&MainArea_5811=5895:0:15,2820:1:0:0:0:0&MainLeft_5895=5825:66508:1:5896:3:0:0
  14. Felsenstein  J. PHYLIP (phylogeny inference package) version 3.2. Cladistics. 1989;5:164–6.
  15. Felsenstein  J. PHYLIP (phylogeny inference package) version 3.5c. Seattle: Department of Genetics, University of Washington; 1993.
  16. Macken  C, Lu  H, Goodman  J, Boykin  L. The value of a database in surveillance and vaccine selection. In: Osterhaus ADME, Cox N, Hampson AW, editors. Options for the control of influenza IV. Amsterdam: Elsevier Science; 2001. p. 103–6.
  17. European Centre for Disease Prevention and Control. Antivirals and antiviral resistance influenza [cited 2008 May 28]. Available from http://ecdc.europa.eu/en/Health_topics/influenza/antivirals_table.aspx
  18. World Health Organization. Influenza A(H1N1) virus resistance to oseltamivir—last quarter 2007 to 5 May 2008 [cited 2008 May 5]. Available from http://www.who.int/csr/disease/influenza/H1N1ResistanceWeb20080505.pdf
  19. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2009 southern hemisphere influenza season [cited 2008 October 5]. Available from http://www.who.int/entity/csr/disease/influenza/200809Recommendation.pdf
  20. World Health Organization. Seasonal influenza activity in the world, 2008 [cited 2008 July 24]. Available from http://www.who.int/csr/disease/influenza/update/en/index.html
  21. World Health Organization. Influenza A(H1N1) virus resistance to oseltamivir [cited 2008 July 18]. Available from http://www.who.int/csr/disease/influenza/h1n1_table/en/index.html
  22. Russell  CA, Jones  TC, Barr  IG, Cox  NJ, Garten  RJ, Gregory  V, The global circulation of seasonal influenza A (H3N2) viruses. Science. 2008;320:340–6. DOIPubMedGoogle Scholar
  23. Herlocher  ML, Carr  J, Ives  J, Elias  S, Truscon  R, Roberts  N, Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets. Antiviral Res. 2002;54:99–111. DOIPubMedGoogle Scholar
  24. Abed  Y, Baz  M, Boivin  G. Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds. Antivir Ther. 2006;11:971–6.PubMedGoogle Scholar
  25. Yen  HL, Ilyushina  NA, Salomon  R, Hoffmann  E, Webster  RG, Govorkova  EA. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J Virol. 2007;81:12418–26. DOIPubMedGoogle Scholar
  26. Rameix-Welti  MA, Enouf  V, Cuvelier  F, Jeannin  P, van der Werf  S. Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir. PLoS Pathog. 2008;4:e1000103. DOIPubMedGoogle Scholar

Main Article

Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external